Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Change in Acquisitions & Divestments: 2021-2024

Historic Change in Acquisitions & Divestments for Praxis Precision Medicines (PRAX) over the last 4 years, with Dec 2024 value amounting to $123.0 million.

  • Praxis Precision Medicines' Change in Acquisitions & Divestments rose 104.06% to $125.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $309.3 million, marking a year-over-year increase of 198.80%. This contributed to the annual value of $123.0 million for FY2024, which is 215.45% up from last year.
  • According to the latest figures from FY2024, Praxis Precision Medicines' Change in Acquisitions & Divestments is $123.0 million, which was up 215.45% from $39.0 million recorded in FY2023.
  • Over the past 5 years, Praxis Precision Medicines' Change in Acquisitions & Divestments peaked at $180.4 million during FY2022, and registered a low of $24.7 million during FY2021.
  • For the 3-year period, Praxis Precision Medicines' Change in Acquisitions & Divestments averaged around $114.1 million, with its median value being $123.0 million (2024).
  • In the last 5 years, Praxis Precision Medicines' Change in Acquisitions & Divestments spiked by 630.18% in 2022 and then plummeted by 78.38% in 2023.
  • Yearly analysis of 4 years shows Praxis Precision Medicines' Change in Acquisitions & Divestments stood at $24.7 million in 2021, then skyrocketed by 630.18% to $180.4 million in 2022, then tumbled by 78.38% to $39.0 million in 2023, then soared by 215.45% to $123.0 million in 2024.